Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | ALKS |
---|---|---|
09:32 ET | 18070 | 26.43 |
09:34 ET | 3300 | 26.055 |
09:36 ET | 21334 | 25.995 |
09:38 ET | 5362 | 26.12 |
09:39 ET | 11008 | 26.255 |
09:41 ET | 10885 | 26.3 |
09:43 ET | 18127 | 26.21 |
09:45 ET | 4619 | 26.23 |
09:48 ET | 16809 | 26.235 |
09:50 ET | 21840 | 26.28 |
09:52 ET | 1615 | 26.24 |
09:54 ET | 36222 | 26.2 |
09:56 ET | 3657 | 26.315 |
09:57 ET | 2451 | 26.31 |
09:59 ET | 466 | 26.27 |
10:01 ET | 7792 | 26.38 |
10:03 ET | 3044 | 26.36 |
10:06 ET | 17481 | 26.34 |
10:08 ET | 1972 | 26.32 |
10:10 ET | 2098 | 26.29 |
10:12 ET | 2617 | 26.285 |
10:14 ET | 5321 | 26.28 |
10:15 ET | 1064 | 26.3 |
10:17 ET | 1051 | 26.305 |
10:19 ET | 1444 | 26.275 |
10:21 ET | 6647 | 26.26 |
10:24 ET | 6643 | 26.09 |
10:26 ET | 3185 | 26.06 |
10:28 ET | 2976 | 26.11 |
10:30 ET | 2493 | 26.12 |
10:32 ET | 3779 | 26.11 |
10:33 ET | 140484 | 26.29 |
10:35 ET | 24776 | 26.385 |
10:37 ET | 29136 | 26.47 |
10:39 ET | 10197 | 26.36 |
10:42 ET | 4027 | 26.35 |
10:44 ET | 2122 | 26.345 |
10:46 ET | 2352 | 26.34 |
10:48 ET | 157577 | 26.43 |
10:50 ET | 3210 | 26.41 |
10:51 ET | 1070 | 26.55 |
10:53 ET | 7477 | 26.45 |
10:55 ET | 2296 | 26.46 |
10:57 ET | 2686 | 26.48 |
11:00 ET | 2519 | 26.495 |
11:02 ET | 3921 | 26.575 |
11:04 ET | 26087 | 26.54 |
11:06 ET | 34806 | 26.466 |
11:08 ET | 9819 | 26.48 |
11:09 ET | 38148 | 26.67 |
11:11 ET | 4186 | 26.735 |
11:13 ET | 1911 | 26.725 |
11:15 ET | 4990 | 26.78 |
11:18 ET | 673 | 26.76 |
11:20 ET | 3184 | 26.836 |
11:22 ET | 2032 | 26.825 |
11:24 ET | 2356 | 26.91 |
11:26 ET | 3892 | 26.92 |
11:27 ET | 1200 | 26.935 |
11:29 ET | 2409 | 26.93 |
11:31 ET | 5100 | 26.97 |
11:33 ET | 700 | 26.99 |
11:36 ET | 4511 | 26.965 |
11:38 ET | 1045 | 26.97 |
11:40 ET | 800 | 26.97 |
11:42 ET | 5031 | 26.98 |
11:44 ET | 3508 | 26.935 |
11:45 ET | 1000 | 26.96 |
11:47 ET | 1584 | 26.945 |
11:49 ET | 1400 | 26.965 |
11:51 ET | 1026 | 26.97 |
11:54 ET | 1113 | 26.9617 |
11:56 ET | 3422 | 26.95 |
11:58 ET | 1914 | 26.94 |
12:00 ET | 1964 | 26.93 |
12:02 ET | 2104 | 26.94 |
12:03 ET | 2233 | 27.01 |
12:05 ET | 2888 | 26.97 |
12:07 ET | 2942 | 26.89 |
12:09 ET | 1372 | 26.89 |
12:12 ET | 768 | 26.93 |
12:14 ET | 500 | 26.94 |
12:16 ET | 2201 | 26.92 |
12:18 ET | 947 | 26.9 |
12:20 ET | 700 | 26.93 |
12:21 ET | 722 | 26.95 |
12:23 ET | 3628 | 26.95 |
12:25 ET | 398 | 26.96 |
12:27 ET | 4401 | 27.005 |
12:30 ET | 3548 | 26.99 |
12:32 ET | 1365 | 27 |
12:34 ET | 2382 | 27.04 |
12:36 ET | 2088 | 27.02 |
12:38 ET | 209 | 27.02 |
12:39 ET | 1536 | 27.02 |
12:41 ET | 2975 | 27 |
12:43 ET | 1297 | 27.025 |
12:45 ET | 1990 | 27.055 |
12:48 ET | 2081 | 27.05 |
12:50 ET | 1756 | 27.03 |
12:52 ET | 2945 | 27.03 |
12:54 ET | 273 | 27.03 |
12:56 ET | 2602 | 27.02 |
12:57 ET | 3308 | 26.97 |
12:59 ET | 3498 | 26.965 |
01:01 ET | 602 | 26.97 |
01:03 ET | 2712 | 26.985 |
01:06 ET | 573 | 26.99 |
01:08 ET | 4881 | 26.97 |
01:10 ET | 1600 | 26.94 |
01:12 ET | 375 | 26.935 |
01:14 ET | 975 | 26.94 |
01:15 ET | 5175 | 26.93 |
01:17 ET | 1400 | 26.885 |
01:19 ET | 1912 | 26.89 |
01:21 ET | 1290 | 26.86 |
01:24 ET | 1386 | 26.875 |
01:26 ET | 1982 | 26.87 |
01:28 ET | 1498 | 26.88 |
01:30 ET | 3833 | 26.87 |
01:32 ET | 600 | 26.92 |
01:33 ET | 5916 | 26.865 |
01:35 ET | 3006 | 26.89 |
01:37 ET | 2200 | 26.915 |
01:39 ET | 2919 | 26.875 |
01:42 ET | 3910 | 26.92 |
01:44 ET | 646 | 26.92 |
01:46 ET | 1901 | 26.895 |
01:48 ET | 3819 | 26.895 |
01:50 ET | 2134 | 26.895 |
01:51 ET | 1810 | 26.895 |
01:53 ET | 5137 | 26.885 |
01:55 ET | 4197 | 26.89 |
01:57 ET | 2985 | 26.885 |
02:00 ET | 3058 | 26.885 |
02:02 ET | 2242 | 26.935 |
02:04 ET | 4372 | 26.9 |
02:06 ET | 2526 | 26.93 |
02:08 ET | 1302 | 26.945 |
02:09 ET | 3739 | 26.895 |
02:11 ET | 668 | 26.89 |
02:13 ET | 1462 | 26.91 |
02:15 ET | 3460 | 26.921 |
02:18 ET | 1054 | 26.94 |
02:20 ET | 889 | 26.97 |
02:22 ET | 1553 | 26.97 |
02:24 ET | 1344 | 26.97 |
02:26 ET | 2469 | 26.976 |
02:27 ET | 3370 | 27.005 |
02:29 ET | 3314 | 27.01 |
02:31 ET | 5278 | 26.96 |
02:33 ET | 1500 | 26.94 |
02:36 ET | 1047 | 26.92 |
02:38 ET | 4773 | 26.89 |
02:40 ET | 307 | 26.89 |
02:42 ET | 1772 | 26.91 |
02:44 ET | 3843 | 26.9 |
02:45 ET | 1000 | 26.91 |
02:47 ET | 3634 | 26.885 |
02:49 ET | 3101 | 26.915 |
02:51 ET | 2210 | 26.9 |
02:54 ET | 1480 | 26.91 |
02:56 ET | 6895 | 26.92 |
02:58 ET | 5023 | 26.91 |
03:00 ET | 1277 | 26.91 |
03:02 ET | 4583 | 26.925 |
03:03 ET | 3433 | 26.925 |
03:05 ET | 6292 | 26.935 |
03:07 ET | 14877 | 26.94 |
03:09 ET | 40056 | 27.0512 |
03:12 ET | 5213 | 27.04 |
03:14 ET | 4024 | 27.05 |
03:16 ET | 3885 | 27.09 |
03:18 ET | 1506 | 27.065 |
03:20 ET | 1600 | 27.06 |
03:21 ET | 3650 | 27.085 |
03:23 ET | 1300 | 27.13 |
03:25 ET | 4246 | 27.09 |
03:27 ET | 5054 | 27.09 |
03:30 ET | 887 | 27.1 |
03:32 ET | 6023 | 27.075 |
03:34 ET | 2607 | 27.015 |
03:36 ET | 9796 | 27 |
03:38 ET | 2330 | 27.015 |
03:39 ET | 2559 | 27.035 |
03:41 ET | 1600 | 27.045 |
03:43 ET | 4034 | 27.08 |
03:45 ET | 18615 | 27.01 |
03:48 ET | 24066 | 27.045 |
03:50 ET | 12098 | 27.085 |
03:52 ET | 18505 | 27.1 |
03:54 ET | 18672 | 27.125 |
03:56 ET | 26331 | 27.13 |
03:57 ET | 47709 | 27.165 |
03:59 ET | 356575 | 27.17 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Alkermes Plc | 4.5B | 10.2x | --- |
Exelixis Inc | 7.5B | 22.5x | -21.77% |
PTC Therapeutics Inc | 2.9B | -6.0x | --- |
P3 Health Partners Inc | 136.6M | -0.7x | --- |
Novavax Inc | 1.9B | -4.4x | --- |
Medpace Holdings Inc | 10.1B | 30.7x | +35.10% |
Alkermes plc is a global biopharmaceutical company that seeks to develop medicines in the field of neuroscience. The Company has a portfolio of commercial products for the treatment of alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder and a pipeline of clinical and preclinical candidates in development for neurological disorders. It focuses on commercial products, such as LYBALVI, ARISTADA/ARISTADA INITIO and VIVITROL, and advancing the development of pipeline programs focused on neurological disorders. LYBALVI is a once-daily, oral atypical antipsychotic drug for the treatment of adults with schizophrenia and for the treatment of adults with bipolar I disorder, as a maintenance monotherapy or for the acute treatment of manic or mixed episodes, as monotherapy or an adjunct to lithium or valproate. ARISTADA is an extended-release intramuscular injectable suspension for the treatment of schizophrenia. It has a manufacturing facility in Wilmington, Ohio.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $4.5B |
---|---|
Revenue (TTM) | $1.5B |
Shares Outstanding | 164.7M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.42 |
EPS | $2.67 |
Book Value | $7.20 |
P/E Ratio | 10.2x |
Price/Sales (TTM) | 3.0 |
Price/Cash Flow (TTM) | 8.8x |
Operating Margin | 24.91% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.